Lauren White

Insider Reports History

Location
Watertown, MA
Signature
/s/ Joseph J. Kenny, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lauren White:

Company Role Class Num Shares Value Price $ Report Date Ownership
C4 Therapeutics, Inc. Chief Financial Officer Common Stock 32,686 $213,113 $6.52 30 Aug 2023 Direct
C4 Therapeutics, Inc. Chief Financial Officer Performance Restricted Stock Units 16,500 $104,940 $6.36 30 Aug 2023 Direct
ImmunoGen, Inc. SVP, CFO AND PFO Restricted Stock Unit 0 $0 $29.30 12 Feb 2024 Direct
ImmunoGen, Inc. SVP, CFO AND PFO Stock Option (Right to Buy) 0 $0 $5.19 12 Feb 2024 Direct
C4 Therapeutics, Inc. Chief Financial Officer Stock Option (Right to Buy) 125,000 13 Feb 2023 Direct

Insider Reports Filed by Lauren White

Symbol Company Period Transactions Value $ Form Type Role Filing Time
IMGN ImmunoGen, Inc. 12 Feb 2024 3 $0 4 SVP, CFO AND PFO 12 Feb 2024, 16:37
IMGN ImmunoGen, Inc. 01 Feb 2024 1 $0 4 SVP, CFO AND PFO 05 Feb 2024, 21:27
IMGN ImmunoGen, Inc. 18 Sep 2023 2 $0 4 SVP, CFO AND PFO 19 Sep 2023, 18:39
IMGN ImmunoGen, Inc. 18 Sep 2023 0 $0 3 SVP, CFO and PFO 19 Sep 2023, 18:37
CCCC C4 Therapeutics, Inc. 30 Aug 2023 3 -$1,937 4 Chief Financial Officer 31 Aug 2023, 17:11
CCCC C4 Therapeutics, Inc. 13 Feb 2023 2 $0 4 Chief Financial Officer 15 Feb 2023, 15:44
CCCC C4 Therapeutics, Inc. 30 Jan 2023 3 -$10,122 4 Chief Financial Officer 01 Feb 2023, 15:10
CCCC C4 Therapeutics, Inc. 26 May 2022 1 -$7,725 4/A Chief Financial Officer 14 Jun 2022, 16:45
CCCC C4 Therapeutics, Inc. 25 May 2022 2 $0 4 Chief Financial Officer 27 May 2022, 16:15
CCCC C4 Therapeutics, Inc. 14 Feb 2022 2 $0 4 Chief Financial Officer 16 Feb 2022, 15:30
CCCC C4 Therapeutics, Inc. 21 Jun 2021 1 $0 4 Chief Financial Officer 21 Jun 2021, 20:22
CCCC C4 Therapeutics, Inc. 21 Jun 2021 0 $0 3 Chief Financial Officer 21 Jun 2021, 20:21